Laman UtamaIMRN • NASDAQ
add
Immuron Ltd - ADR
$0.88
Selepas Waktu Dagangan:(0.82%)-0.0072
$0.87
Tutup: 24 Dis, 2:52:45 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$0.91
Julat hari
$0.88 - $0.93
Julat tahun
$0.88 - $2.48
Permodalan pasaran
8.00J USD
Bilangan Purata
876.10K
Nisbah P/E
-
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (AUD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.65J | 29.26% |
Perbelanjaan pengendalian | 2.46J | -0.53% |
Pendapatan bersih | -1.36J | 43.93% |
Margin untung bersih | -82.83 | 56.62% |
Pendapatan bagi setiap syer | — | — |
EBITDA | -1.40J | 11.97% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (AUD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 5.87J | -49.67% |
Jumlah aset | 10.13J | -34.86% |
Jumlah liabiliti | 2.06J | -27.45% |
Jumlah ekuiti | 8.07J | — |
Syer tertunggak | 268.22J | — |
Harga kepada buku | 30.44 | — |
Pulangan pada aset | -34.77% | — |
Pulangan pada modal | -43.03% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (AUD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -1.36J | 43.93% |
Tunai daripada operasi | -1.07J | 44.70% |
Tunai daripada pelaburan | -1.48J | -1,797.41% |
Tunai daripada pembiayaan | 120.82K | 906.88% |
Perubahan bersih dalam tunai | -2.45J | -37.95% |
Aliran tunai bebas | -704.67K | 27.75% |
Perihal
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Diasaskan
1994
Ibu pejabat
Tapak web
Pekerja
7
